People · Operator
Named in public records as an officer, director or promoter · active 2013–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Guardant Health, Inc. | — | Biotechnology | Series D+ | $500.0M | $13.2B | 2013 |
| uLab Systems, Inc. | — | Biotechnology | Series C | $90.9M | $2.8B | 2021 |
AmirAli Talasaz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside AmirAli Talasaz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Samir Kaul | 1 | 32 |
| Amir Abolfathi | 1 | 8 |
| Aaref Hilaly | 1 | 6 |
| Mark Foley | 1 | 5 |
| David Thrower | 1 | 5 |
| Michael Wiley | 1 | 4 |
| Robin Bienfait | 1 | 2 |
| Helmy Eltoukhy | 1 | 2 |
| Warren Hogarth | 1 | 2 |
| Rita O'Connor | 1 | 2 |
| Mic Falkel | 1 | 2 |
| Hal Beckham | 1 | 1 |
| Robert Doty | 1 | 1 |
| Nicola Downes | 1 | 1 |
| Huafeng Wen | 1 | 1 |
| Robin McCord | 1 | 1 |
| Daniel Gorback | 1 | 1 |
| Samir Kaur | 1 | 1 |
| Tim Dumore | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.